-
- Target Alle PNPLA2 Antikörper anzeigen
- PNPLA2 (Patatin-Like phospholipase Domain Containing 2 (PNPLA2))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PNPLA2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- ATGL/PNPLA2 Rabbit mAb
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Monoclonal Antibodies
- Aufreinigung
- Affinity purification
- Immunogen
- A synthesized peptide derived from human ATGL / PNPLA2
- Isotyp
- IgG
- Top Product
- Discover our top product PNPLA2 Primärantikörper
-
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (AA 1-504) antibody
PNPLA2 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (AA 347-446) antibodyPNPLA2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2H1 unconjugated
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (AA 265-504) antibodyPNPLA2 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (AA 49-78), (N-Term) antibodyPNPLA2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB40409 unconjugated
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (Internal Region) antibodyPNPLA2 Reaktivität: Human, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (AA 265-504) antibodyPNPLA2 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (Internal Region) antibodyVerified PNPLA2 Reaktivität: Human WB, ELISA, IHC Wirt: Ziege Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (AA 465-486) antibodyPNPLA2 Reaktivität: Maus IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (AA 401-504) antibodyPNPLA2 Reaktivität: Human, Maus WB, ELISA, FACS, IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (AA 347-446) antibodyPNPLA2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
- WB,1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- PNPLA2 (Patatin-Like phospholipase Domain Containing 2 (PNPLA2))
- Andere Bezeichnung
- PNPLA2 (PNPLA2 Produkte)
- Synonyme
- 1110001C14Rik antikoerper, ATGL antikoerper, PEDF-R antikoerper, TTS-2.2 antikoerper, TTS2 antikoerper, iPLA2zeta antikoerper, PNPLA2 antikoerper, pnpla2 antikoerper, 0610039C21Rik antikoerper, Atgl antikoerper, RGD1309044 antikoerper, patatin like phospholipase domain containing 2 antikoerper, patatin-like phospholipase domain containing 2 antikoerper, PNPLA2 antikoerper, pnpla2 antikoerper, Pnpla2 antikoerper
- Hintergrund
- This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy. [provided by RefSeq, Jul 2010],1110001C14Rik, ATGL, FP17548, PEDF-R, TTS-2.2, TTS2, iPLA2zeta,Cardiovascular,Endocrine & Metabolism,Endocrine and metabolic diseases,Endocrine and metabolic diseases_Metabolic disorders,Endocrine and metabolic diseases_Obesity,Lipid Metabolism,Lipid Metabolism_Lipases,Lipids,Signal Transduction,PNPLA2
- Molekulargewicht
- 55kDa
- Gen-ID
- 57104
- UniProt
- Q96AD5
-
Sie sind hier:
